Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer
Cancer Research and Treatment. 2018;50(4):1418-1432 
The Clinical Significance of the Estrogen Receptor β Expression for Endocrine Therapy in Patients with ERα-negative and Progesterone Receptor-positive Breast Carcinoma
Journal of Breast Cancer. 2009;12(3):156
Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer
Breast Cancer Research. 2007;9(S1):
Triple Negative Receptor Status is Associated with Poor Outcomes for Lymph Node Positive Breast Cancer Treated with Mastectomy and Modern Systemic Therapy
International Journal of Radiation Oncology*Biology*Physics. 2011;81(2):S218
Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma
Cancer. 1999;86(11):2259-2265
A high number of tumor free axillary lymph nodes from patients with lymph node negative breast is associated with poor outcome
Cancer. 2000;89(1):218-218
A high number of tumor free axillary lymph nodes from patients with lymph node negative breast is associated with poor outcome
Cancer. 2000;89(1):218-218
Adjuvant Systemic Treatment in Hormone Receptor Positive, HER2 Negative Breast Cancer
Breast Cancer and Surgery. 2018;
Clinical pattern of primary systemic therapy and outcomes of estrogen receptor-positive, HER2-negative metastatic breast cancer: a review of a single institution
Breast Cancer Research and Treatment. 2017;166(3):911-917
Influence of younger age to disease outcome in patients with breast cancer after adjuvant systemic chemotherapy and adjuvant hormone therapy
The Breast. 2017;32:S100